| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8881 | 
      | Human Intestinal Absorption | HIA+ | 0.9825 | 
      | Caco-2 Permeability | Caco2+ | 0.5210 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8440 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8794 | 
                                                     | Non-inhibitor | 0.9631 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8980 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5334 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7007 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.9024 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6859 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8965 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9097 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9463 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9049 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8046 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5898 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9858 | 
                                                                    | Non-inhibitor | 0.8063 | 
      | AMES Toxicity | Non AMES toxic | 0.7578 | 
      | Carcinogens | Non-carcinogens | 0.8624 | 
      | Fish Toxicity | Low FHMT | 0.7229 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.5527 | 
      | Honey Bee Toxicity | Low HBT | 0.7686 | 
      | Biodegradation | Not ready biodegradable | 0.9970 | 
      | Acute Oral Toxicity | IV | 0.5028 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5131 |